coronary artery disease
University of Sydney Wins A$1.4M Grant, Teams With Allelica on Cardiac Polygenic Risk Scores
Researchers at the University of Sydney will work with Allelica to develop polygenic risk scores for coronary artery disease prevention and integrate the testing into primary care.
Invitae to Provide Genetic Testing Within eMERGE Population Screening Study
As a new clinical affiliate, Invitae will test up to 25,000 patients in a study exploring the role of genetics in cancer, heart disease, and other conditions.
Meta-Analysis Supports Pharmacogenomic Testing Prior to Anti-Platelet Therapy
The study showed that CYP2C19 genotyping could help clinicians reduce ischemic events in patients with coronary artery disease by tailoring their treatment.
In two recent papers, the UK startup demonstrated the integration of polygenic risk scoring into primary care screening and workflows.
Coronary Artery Disease Loci Identified in Japanese GWAS, Trans-Ancestry Meta-Analysis
Researchers found ancestry-specific risk variants and developed a better polygenic risk score based on a GWAS and subsequent meta-analysis.